Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state

Molecular Cell

Volumn 12, Issue 1, 2003, Pages 51-62

  Fulco, Marcella ^a   Schiltz, R Louis ^a   Iezzi, Simona ^a   King, M Todd ^b   Zhao, Po ^c   Kashiwaya, Yoshihiro ^b   Hoffman, Eric ^c   Veech, Richard L ^b   Sartorelli, Vittorio ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE DEPENDENT ACETYLASE; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SILENT INFORMATION REGULATOR PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; BIOSENSOR; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXERCISE; FOOD INTAKE; GENE EXPRESSION; HUMAN; HUMAN CELL; MUSCLE DEVELOPMENT; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION STATE; PROTEIN FUNCTION; SENSOR; SKELETAL MUSCLE; STARVATION; UNINDEXED SEQUENCE;

EID: 0043244921     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00226-0     Document Type: Article

References (44)

1. Barlow A.L., van Drunen C.M., Johnson C.A., Tweedie S., Bird A., Turner B.M. dSIR2 and dHDAC6. two novel, inhibitor-resistant deacetylases in Drosophila melanogaster Exp. Cell Res. 265:2001;90-103.
2. Bedalov A., Gatbonton T., Irvine W.P., Gottschling D.E., Simon J.A. Identification of a small molecule inhibitor of Sir2p. Proc. Natl. Acad. Sci. USA. 98:2001;15113-15118.
3. Bergstrom D.A., Penn B.H., Strand A., Perry R.L., Rudnicki M.A., Tapscott S.J. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell. 9:2002;587-600.
4. Bitterman K.J., Anderson R.M., Cohen H.Y., Latorre-Esteves M., Sinclair D.A. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J. Biol. Chem. 277:2002;45099-45107.
5. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273:2000;793-798.
6. Grozinger C.M., Schreiber S.L. Deacetylase enzymes. biological functions and the use of small-molecule inhibitors Chem. Biol. 9:2002;3-16.
7. Grozinger C.M., Chao E.D., Blackwell H.E., Moazed D., Schreiber S.L. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J. Biol. Chem. 276:2001;38837-38843.
8. Guarente L. Sir2 links chromatin silencing, metabolism, and aging. Genes Dev. 14:2000;1021-1026.
9. Iezzi S., Cossu G., Nervi C., Sartorelli V., Puri P.L. Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases. Proc. Natl. Acad. Sci. USA. 99:2002;7757-7762.
10. Imai S., Armstrong C.M., Kaeberlein M., Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 403:2000;795-800.
11. Kaeberlein M., McVey M., Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13:1999;2570-2580.
12. Krebs H.A., Veech R.L. Equilibrium relations between pyridine nucleotides and adenine nucleotides and their roles in the regulation of metabolic processes. Adv. Enzyme Regul. 7:1969;397-413.
13. Landry J., Sutton A., Tafrov S.T., Heller R.C., Stebbins J., Pillus L., Sternglanz R. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc. Natl. Acad. Sci. USA. 97:2000;5807-5811.
14. Langley E., Pearson M., Faretta M., Bauer U.M., Frye R.A., Minucci S., Pelicci P.G., Kouzarides T. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21:2002;2383-2396.
15. Lin S.J., Guarente L. Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr. Opin. Cell Biol. 15:2003;241-246.
16. Lu J., McKinsey T.A., Zhang C.L., Olson E.N. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell. 6:2000;233-244.
17. Luo J., Nikolaev A.Y., Imai S., Chen D., Su F., Shiloh A., Guarente L., Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 107:2001;137-148.
18. MacDonald M.J., Marshall L.K. Mouse lacking NAD+-linked glycerol phosphate dehydrogenase has normal pancreatic beta cell function but abnormal metabolite pattern in skeletal muscle. Arch. Biochem. Biophys. 384:2000;143-153.
19. Mal A., Sturniolo M., Schiltz R.L., Ghosh M.K., Harter M.L. A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD. inhibition of the myogenic program EMBO J. 20:2001;1739-1753.
20. McBurney M.W., Yang X., Jardine K., Hixon M., Boekelheide K., Webb J.R., Lansdorp P.M., Lemieux M. The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol. Cell. Biol. 23:2003;38-54.
21. McKinsey T.A., Zhang C.L., Olson E.N. Signaling chromatin to make muscle. Curr. Opin. Cell Biol. 14:2002;763-772.
22. Moazed D. Enzymatic activities of Sir2 and chromatin silencing. Curr. Opin. Cell Biol. 13:2001;232-238.
23. Newman B.L., Lundblad J.R., Chen Y., Smolik S.M. A Drosophila homologue of sir2 modifies position-effect variegation but does not affect life span. Genetics. 162:2002;1675-1685.
24. Polesskaya A., Duquet A., Naguibneva I., Weise C., Vervisch A., Bengal E., Hucho F., Robin P., Harel-Bellan A. CREB-binding Protein/p300 activates MyoD by acetylation. J. Biol. Chem. 275:2000;34359-34364.
25. Puri P.L., Sartorelli V., Yang X.J., Hamamori Y., Ogryzko V.V., Howard B.H., Kedes L., Wang J.Y., Graessmann A., Nakatani Y.et al. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell. 1:1997;35-45.
26. Puri P.L., Iezzi S., Stiegler P., Chen T.T., Schiltz R.L., Muscat G.E., Giordano A., Kedes L., Wang J.Y., Sartorelli V. Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol. Cell. 8:2001;885-897.
27. Rine J., Herskowitz I. Four genes responsible for a position effect on expression from HML and HMR in Saccharomyces cerevisiae. Genetics. 116:1987;9-22.
28. Rosenberg M.I., Parkhurst S.M. Drosophila Sir2 is required for heterochromatic silencing and by euchromatic Hairy/E(Spl) bHLH repressors in segmentation and sex determination. Cell. 109:2002;447-458.
29. Sartorelli V., Puri P.L. The link between chromatin structure, protein acetylation and cellular differentiation. Front. Biosci. 6:2001;D1024-D1047.
30. Sartorelli V., Puri P.L., Hamamori Y., Ogryzko V., Chung G., Nakatani Y., Wang J.Y., Kedes L. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol. Cell. 4:1999;725-734.
31. Schiltz R.L., Nakatani Y. The PCAF acetylase complex as a potential tumor suppressor. Biochim. Biophys. Acta. 1470:2000;M37-M53.
32. Smith J.S., Brachmann C.B., Celic I., Kenna M.A., Muhammad S., Starai V.J., Avalos J.L., Escalante-Semerena J.C., Grubmeyer C., Wolberger C.et al. A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc. Natl. Acad. Sci. USA. 97:2000;6658-6663.
33. Starai V.J., Celic I., Cole R.N., Boeke J.D., Escalante-Semerena J.C. Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine. Science. 298:2002;2390-2392.
34. Takata T., Ishikawa F. Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1 and HEY2 and is involved in HES1- and HEY2-mediated transcriptional repression. Biochem. Biophys. Res. Commun. 301:2003;250-257.
35. Tanny J.C., Moazed D. Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2. evidence for acetyl transfer from substrate to an NAD breakdown product Proc. Natl. Acad. Sci. USA. 98:2001;415-420.
36. Tissenbaum H.A., Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature. 410:2001;227-230.
37. Vaziri H., Dessain S.K., Ng Eaton E., Imai S.I., Frye R.A., Pandita T.K., Guarente L., Weinberg R.A. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 107:2001;149-159.
38. Veech R.L., Eggleston L.V., Krebs H.A. The redox state of free nicotinamide-adenine dinucleotide phosphate in the cytoplasm of rat liver. Biochem. J. 115:1969;609-619.
39. Wells J., Boyd K.E., Fry C.J., Bartley S.M., Farnham P.J. Target gene specificity of E2F and pocket protein family members in living cells. Mol. Cell. Biol. 20:2000;5797-5807.
40. Xu Q., Wu Z. The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J. Biol. Chem. 275:2000;36750-36757.
41. Xu W., Edmondson D.G., Evrard Y.A., Wakamiya M., Behringer R.R., Roth S.Y. Loss of gcn5l2 leads to increased apoptosis and mesodermal defects during mouse development. Nat. Genet. 26:2000;229-232.
42. Yang X.J., Ogryzko V.V., Nishikawa J., Howard B.H., Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature. 382:1996;319-324.
43. Zhang Q., Piston D.W., Goodman R.H. Regulation of corepressor function by nuclear NADH. Science. 295:2002;1895-1897.
44. Zhao P., Iezzi S., Carver E., Dressman D., Gridley T., Sartorelli V., Hoffman E.P. Slug is a novel downstream target of MyoD. Temporal profiling in muscle regeneration. J. Biol. Chem. 277:2002;30091-30101.